IMPORTANT: You must view the program in it's entirety in order to receive full credit. Otherwise, your generated CE statement will produce zero (0) contact hours.
Please fill out your information when prompted prior to viewing the webinar - as this will be required to generate your automatic statement of credit. If you have already pre-registered, we do apologize for any inconvenience.
Target Audience: Pharmacists, Certified Pharmacy Technicians, Nurses, Healthcare Risk Managers
Fees: No Charge
Accreditation
This knowledge-based program has been accredited for 1.0 contact hour of continuing education credit for pharmacists and pharmacy technicians.
The National Pharmacy Technician Association is accredited by
the Accreditation Council for Pharmacy Education (ACPE) as a provider of
continuing pharmacy education.
®
This knowledge-based program has been accredited for 1.0 contact hour of continuing education credit for pharmacists and pharmacy technicians.
UAN: 0384-9999-10-002-C04-P 0384-9999-10-002-C04-T
This program has been approved for a total of 1 contact hour of continuing education credit toward fulfillment of the requirements of ASHRM designations of Fellow (FASHRM) and Distinguished Fellow (DFASHRM) and towards Certified Professional in Healthcare Risk Management (CPHRM) renewal.
The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is provided for 1.0 contact hours under ANCC criteria. Provided for 1.2 contact hours under Iowa Provider #78. Provider approved by the California Board of Registered Nursing, Provider #13699 for 1.2 contact hours.
Faculty
Shannon Hazen, RN, BSN, OCN
Regional Oncology Education Coordinator
Presbyterian Cancer Center
Charlotte, NC
Scott W. Savage, Pharm.D., M.S.
Pharmacy Clinical Manager
UNC Health Care
N.C. Cancer Hospital
Chapel Hill, NC
Timothy Tyler, PharmD, FCSHP
Director of Pharmacy Services
Comprehensive Cancer Center
Desert Regional Medical Center
Palm Springs, CA
Learning Objectives (for all participants)
At the conclusion of this activity, participants should be able to:
-
Discuss rationale and benefits of vial optimization;
-
Outline the history and implementation of USP Chapter <797>’s single-dose container standard;
-
To recount the major barriers remaining in improving the safety regarding the preparation of hazardous drugs;
-
To review seminal evidence on the utility of a CSTD (Closed System Transfer Device) in the preparation of hazardous drugs.
-
Review prior data exploring methods for vial optimization and its associated limitations;
-
Characterize the projected institutional benefit of hazardous waste reduction measures via a closed-system transfer device (CSTD);
-
Identify 2 potential barriers to implementation of evidence based practice change;
-
Describe why safe handling education is important prior to implementation of a closed-system transfer device.
Disclosures
• This program has been peer reviewed to ensure accuracy, balance and non-commercialization.
• Commercial support for this program has been provided by Carmel Pharma, Inc.
• Timothy Tyler disclosed having consulting roles with Sanofi-Aventis, TopoTarget, J & J Solutions and ICore, as well as being on the Speakers Bureau of Centocor OBI, Bristol-Myers-Squibb, Amgen and Eisai. Shannon Hazen and Scott Savage did not have any disclosures to make. No conflicts of interests related to the continuing education activity were determined with any of the faculty.
• This program is intended strictly for educational purposes and does not constitute as an endorsement of any product or off-label usage.
Handouts
Click Here to download a copy of the presentation handouts.
